Cephalexin Prescribing for Skin Infections
For typical uncomplicated skin infections in adults, prescribe cephalexin 500 mg orally four times daily (every 6 hours) for 5 days, extending only if clinical improvement has not occurred within this timeframe. 1, 2, 3
Standard Adult Dosing
- The FDA-approved adult dosage is 250 mg every 6 hours for routine skin infections, with 500 mg every 12 hours as an alternative for uncomplicated cases. 3
- The Infectious Diseases Society of America recommends cephalexin 500 mg orally every 6 hours as the preferred oral beta-lactam for methicillin-susceptible Staphylococcus aureus (MSSA) skin and soft tissue infections. 1
- For more severe infections or less susceptible organisms, doses up to 4 grams daily in divided doses may be required. 3
Pediatric Dosing
- The usual pediatric dose is 25-50 mg/kg/day divided into four doses (every 6 hours). 1, 3
- For streptococcal pharyngitis and skin infections in children over 1 year, the total daily dose may be divided and given every 12 hours instead. 3
- For severe infections, the pediatric dosage may be doubled. 3
- Children may require higher doses per kilogram than adults due to greater body water turnover. 4
Treatment Duration
- Treat for exactly 5 days if clinical improvement occurs; extend only if symptoms have not improved within this timeframe. 2
- For β-hemolytic streptococcal infections specifically, administer cephalexin for at least 10 days. 3
- Traditional 7-14 day courses are no longer necessary for uncomplicated cases. 2
Renal Dosing Adjustments
- Patients with creatinine clearance less than 30 mL/min require dose reduction proportional to their reduced renal function. 4
- For GFR of 59 mL/min, no dose adjustment is needed—use standard dosing of 500 mg every 6 hours. 2
When Cephalexin Is Appropriate
- Cephalexin is appropriate for nonpurulent cellulitis without drainage, exudate, or MRSA risk factors. 2
- It provides excellent coverage against beta-hemolytic streptococci (especially Streptococcus pyogenes) and methicillin-sensitive Staphylococcus aureus. 1, 2
- Use cephalexin for impetigo at 250 mg four times daily in adults or 25 mg/kg/day in four divided doses for children. 1
When NOT to Use Cephalexin Alone
- Do NOT use cephalexin monotherapy when MRSA risk factors are present: penetrating trauma, injection drug use, purulent drainage/exudate, known MRSA colonization, or systemic inflammatory response syndrome (SIRS). 2
- In these scenarios, switch to clindamycin 300-450 mg orally four times daily (covers both streptococci and MRSA), or combine trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily PLUS a beta-lactam. 1, 2
- For severe cellulitis with systemic toxicity, hospitalization with IV vancomycin 15-20 mg/kg every 8-12 hours PLUS piperacillin-tazobactam is mandatory. 2
Penicillin Allergy Considerations
- For patients with penicillin allergy (except immediate hypersensitivity reactions), cephalexin remains an option. 1
- Cross-reactivity between penicillins and cephalosporins is only 2-4%, primarily based on R1 side chain similarity rather than the beta-lactam ring. 1
- Cephalexin shares identical R1 side chains with amoxicillin, so avoid cephalexin in patients with confirmed immediate-type amoxicillin allergy. 1, 5
- For patients with severe immediate-type reactions to any penicillin, use clindamycin 300-450 mg four times daily instead. 2, 5
Cephalosporin Cross-Allergy
- Patients with suspected immediate-type allergy to cephalexin can receive penicillins with dissimilar side chains (avoid amoxicillin/ampicillin). 1
- Cephalosporins with dissimilar side chains can be used in patients with cephalexin allergy, irrespective of severity or timing. 1
- Any carbapenem can be safely used in patients with cephalexin allergy. 1
Special Populations
- Cephalexin is safe in myasthenia gravis—it does not trigger or exacerbate the condition, unlike fluoroquinolones, aminoglycosides, or macrolides. 6
- For diabetic foot infections, cephalexin may be used for mild infections, but moderate-to-severe cases require broader coverage with amoxicillin-clavulanate or fluoroquinolones. 2
Critical Pitfalls to Avoid
- Do NOT reflexively extend treatment to 10-14 days based on residual erythema alone—some inflammation persists after bacterial eradication. 2
- Do NOT add MRSA coverage routinely for typical cellulitis—beta-lactam monotherapy succeeds in 96% of cases. 2
- Do NOT use doxycycline or trimethoprim-sulfamethoxazole as monotherapy for typical cellulitis—their streptococcal coverage is unreliable. 2
- Assess for abscess with ultrasound if clinically uncertain—purulent collections require incision and drainage, not antibiotics alone. 2
Adjunctive Measures
- Elevate the affected extremity above heart level for at least 30 minutes three times daily to promote drainage. 2
- Examine interdigital toe spaces for tinea pedis and treat toe web abnormalities to reduce recurrence risk. 2
- Address predisposing conditions including venous insufficiency, lymphedema, and chronic edema. 2